<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p147" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_147{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_147{left:306px;bottom:30px;}
#t3_147{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_147{left:346px;bottom:30px;}
#t5_147{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_147{left:517px;bottom:30px;}
#t7_147{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_147{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_147{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_147{left:1124px;bottom:27px;letter-spacing:0.2px;}
#tb_147{left:35px;bottom:777px;letter-spacing:0.24px;word-spacing:-0.05px;}
#tc_147{left:35px;bottom:748px;letter-spacing:0.12px;word-spacing:0.07px;}
#td_147{left:35px;bottom:724px;letter-spacing:0.04px;word-spacing:0.15px;}
#te_147{left:35px;bottom:701px;letter-spacing:0.01px;word-spacing:-1.06px;}
#tf_147{left:35px;bottom:678px;letter-spacing:0.09px;word-spacing:0.1px;}
#tg_147{left:35px;bottom:655px;letter-spacing:0.16px;word-spacing:0.03px;}
#th_147{left:35px;bottom:633px;letter-spacing:0.12px;word-spacing:-0.65px;}
#ti_147{left:35px;bottom:610px;letter-spacing:0.13px;word-spacing:-0.28px;}
#tj_147{left:35px;bottom:586px;letter-spacing:0.11px;word-spacing:0.07px;}
#tk_147{left:35px;bottom:563px;letter-spacing:0.12px;word-spacing:0.07px;}
#tl_147{left:35px;bottom:540px;letter-spacing:0.02px;word-spacing:0.16px;}
#tm_147{left:456px;bottom:540px;letter-spacing:0.1px;word-spacing:0.08px;}
#tn_147{left:35px;bottom:517px;letter-spacing:0.25px;}
#to_147{left:101px;bottom:517px;letter-spacing:0.12px;word-spacing:0.07px;}
#tp_147{left:35px;bottom:493px;letter-spacing:0.09px;word-spacing:0.1px;}
#tq_147{left:35px;bottom:453px;letter-spacing:0.15px;word-spacing:0.04px;}
#tr_147{left:35px;bottom:430px;letter-spacing:0.11px;word-spacing:-0.75px;}
#ts_147{left:35px;bottom:407px;letter-spacing:0.19px;}
#tt_147{left:35px;bottom:383px;letter-spacing:0.06px;word-spacing:-0.15px;}
#tu_147{left:35px;bottom:360px;letter-spacing:0.14px;word-spacing:0.05px;}
#tv_147{left:35px;bottom:337px;letter-spacing:0.13px;word-spacing:0.06px;}
#tw_147{left:35px;bottom:314px;letter-spacing:0.09px;word-spacing:0.1px;}
#tx_147{left:35px;bottom:291px;letter-spacing:0.11px;word-spacing:0.07px;}
#ty_147{left:35px;bottom:267px;letter-spacing:0.14px;word-spacing:0.05px;}
#tz_147{left:35px;bottom:244px;letter-spacing:0.1px;word-spacing:-0.19px;}
#t10_147{left:35px;bottom:221px;letter-spacing:0.16px;word-spacing:0.02px;}
#t11_147{left:35px;bottom:198px;letter-spacing:0.05px;word-spacing:-0.98px;}
#t12_147{left:35px;bottom:174px;word-spacing:0.18px;}
#t13_147{left:35px;bottom:151px;letter-spacing:0.14px;word-spacing:-0.2px;}
#t14_147{left:35px;bottom:128px;letter-spacing:0.07px;word-spacing:-0.62px;}
#t15_147{left:35px;bottom:105px;letter-spacing:0.08px;word-spacing:-0.27px;}
#t16_147{left:35px;bottom:82px;letter-spacing:0.09px;word-spacing:0.09px;}
#t17_147{left:35px;bottom:58px;word-spacing:-0.9px;}
#t18_147{left:618px;bottom:777px;letter-spacing:0.11px;word-spacing:0.07px;}
#t19_147{left:618px;bottom:754px;letter-spacing:0.09px;word-spacing:0.09px;}
#t1a_147{left:618px;bottom:731px;letter-spacing:0.1px;word-spacing:-0.04px;}
#t1b_147{left:618px;bottom:707px;letter-spacing:0.16px;word-spacing:0.17px;}
#t1c_147{left:618px;bottom:684px;letter-spacing:0.1px;word-spacing:-0.74px;}
#t1d_147{left:618px;bottom:661px;letter-spacing:0.1px;word-spacing:0.08px;}
#t1e_147{left:618px;bottom:638px;letter-spacing:0.1px;word-spacing:0.09px;}
#t1f_147{left:618px;bottom:596px;letter-spacing:-0.29px;word-spacing:2.28px;}
#t1g_147{left:618px;bottom:568px;letter-spacing:0.22px;}
#t1h_147{left:618px;bottom:539px;letter-spacing:0.15px;word-spacing:-0.37px;}
#t1i_147{left:618px;bottom:515px;letter-spacing:0.07px;word-spacing:0.12px;}
#t1j_147{left:618px;bottom:492px;letter-spacing:0.04px;word-spacing:0.14px;}
#t1k_147{left:618px;bottom:469px;letter-spacing:0.2px;word-spacing:-0.01px;}
#t1l_147{left:618px;bottom:446px;word-spacing:-0.56px;}
#t1m_147{left:907px;bottom:453px;letter-spacing:0.15px;}
#t1n_147{left:939px;bottom:446px;letter-spacing:0.09px;word-spacing:-0.15px;}
#t1o_147{left:618px;bottom:423px;letter-spacing:0.01px;word-spacing:-0.14px;}
#t1p_147{left:860px;bottom:430px;letter-spacing:-0.01px;}
#t1q_147{left:893px;bottom:423px;letter-spacing:0.07px;word-spacing:0.12px;}
#t1r_147{left:618px;bottom:399px;letter-spacing:0.09px;word-spacing:-0.59px;}
#t1s_147{left:618px;bottom:376px;letter-spacing:0.08px;word-spacing:0.11px;}
#t1t_147{left:900px;bottom:384px;}
#t1u_147{left:917px;bottom:376px;letter-spacing:0.07px;word-spacing:0.11px;}
#t1v_147{left:618px;bottom:353px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1w_147{left:618px;bottom:330px;letter-spacing:0.06px;word-spacing:0.12px;}
#t1x_147{left:618px;bottom:306px;letter-spacing:0.18px;}
#t1y_147{left:618px;bottom:266px;letter-spacing:0.28px;word-spacing:-0.09px;}
#t1z_147{left:618px;bottom:238px;letter-spacing:0.04px;word-spacing:0.14px;}
#t20_147{left:618px;bottom:215px;letter-spacing:0.09px;word-spacing:-1.02px;}
#t21_147{left:618px;bottom:192px;letter-spacing:0.08px;word-spacing:-0.45px;}
#t22_147{left:618px;bottom:168px;letter-spacing:0.05px;word-spacing:0.14px;}
#t23_147{left:1043px;bottom:168px;letter-spacing:0.18px;word-spacing:0.01px;}
#t24_147{left:618px;bottom:145px;letter-spacing:-0.03px;word-spacing:0.21px;}
#t25_147{left:618px;bottom:122px;letter-spacing:-0.1px;}
#t26_147{left:703px;bottom:122px;letter-spacing:0.24px;}
#t27_147{left:775px;bottom:122px;letter-spacing:-0.31px;}
#t28_147{left:808px;bottom:122px;letter-spacing:0.32px;}
#t29_147{left:912px;bottom:122px;letter-spacing:0.12px;word-spacing:0.06px;}
#t2a_147{left:618px;bottom:99px;letter-spacing:0.08px;word-spacing:0.1px;}
#t2b_147{left:1008px;bottom:99px;letter-spacing:0.22px;}
#t2c_147{left:1050px;bottom:99px;letter-spacing:0.3px;word-spacing:-0.12px;}
#t2d_147{left:618px;bottom:75px;letter-spacing:0.2px;word-spacing:-0.02px;}
#t2e_147{left:823px;bottom:75px;letter-spacing:0.15px;}
#t2f_147{left:869px;bottom:75px;letter-spacing:0.11px;word-spacing:0.08px;}
#t2g_147{left:618px;bottom:52px;letter-spacing:0.08px;word-spacing:0.1px;}
#t2h_147{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_147{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_147{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_147{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_147{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_147{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_147{font-size:17px;font-family:Arial-ItalicMT_kb;color:#000;}
.s6_147{font-size:20px;font-family:Arial-BoldMT_5te;color:#000;}
.s7_147{font-size:11px;font-family:ArialMT_5tg;color:#000;}
.s8_147{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts147" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-ItalicMT_kb;
	src: url("fonts/Arial-ItalicMT_kb.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg147Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg147" style="-webkit-user-select: none;"><object width="1210" height="935" data="147/147.svg" type="image/svg+xml" id="pdf147" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_147" class="t s0_147">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_147" class="t s1_147">© </span>
<span id="t3_147" class="t s0_147">(NCCN </span>
<span id="t4_147" class="t s1_147">© </span>
<span id="t5_147" class="t s0_147">), All rights reserved. NCCN Guidelines </span>
<span id="t6_147" class="t s1_147">® </span>
<span id="t7_147" class="t s0_147">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_147" class="t s2_147">NCCN Guidelines Version 4.2024 </span>
<span id="t9_147" class="t s2_147">Head and Neck Cancers </span>
<span id="ta_147" class="t s3_147">MS-6 </span>
<span id="tb_147" class="t s3_147">Resectable Versus Unresectable Disease </span>
<span id="tc_147" class="t s4_147">The NCCN Member Institutions have teams experienced in the </span>
<span id="td_147" class="t s4_147">comprehensive treatment of H&amp;N cancers and maintain the </span>
<span id="te_147" class="t s4_147">multidisciplinary infrastructure needed for reconstruction and rehabilitation. </span>
<span id="tf_147" class="t s4_147">A patient’s cancer is deemed unresectable if H&amp;N surgeons at NCCN </span>
<span id="tg_147" class="t s4_147">Member Institutions do not think they can remove the gross tumor on </span>
<span id="th_147" class="t s4_147">anatomic grounds or if local control is unlikely to be achieved with surgery </span>
<span id="ti_147" class="t s4_147">(even with the addition of RT to the treatment approach). Typically, these </span>
<span id="tj_147" class="t s4_147">unresectable tumors densely involve the prevertebral fascia, cervical </span>
<span id="tk_147" class="t s4_147">vertebrae, skull base, brachial plexus, deep muscles of the neck, </span>
<span id="tl_147" class="t s4_147">mediastinal structures, or critical H&amp;N vasculature (see </span><span id="tm_147" class="t s5_147">Principles of </span>
<span id="tn_147" class="t s5_147">Surgery </span><span id="to_147" class="t s4_147">in the NCCN Guidelines for Head and Neck Cancers). </span>
<span id="tp_147" class="t s4_147">Unresectable tumors are associated with overall poor prognosis. </span>
<span id="tq_147" class="t s4_147">Unresectable tumors should be distinguished from inoperable tumors in </span>
<span id="tr_147" class="t s4_147">those patients whose constitutional state of health precludes an operation </span>
<span id="ts_147" class="t s4_147">(even if the cancer could be readily resected with few sequelae). </span>
<span id="tt_147" class="t s4_147">Additionally, a subgroup of patients will decline surgical management, but </span>
<span id="tu_147" class="t s4_147">their tumors should not be deemed unresectable. In some patients, </span>
<span id="tv_147" class="t s4_147">adequate reconstructive options may be lacking; therefore, the patient’s </span>
<span id="tw_147" class="t s4_147">disease is considered functionally unresectable. Examples include </span>
<span id="tx_147" class="t s4_147">bilateral orbital exenteration or exenteration in the only seeing eye, </span>
<span id="ty_147" class="t s4_147">extensive mandibular resection without reconstruction options, or total </span>
<span id="tz_147" class="t s4_147">pharyngectomy when reconstitution of the alimentary tract is not feasible. </span>
<span id="t10_147" class="t s4_147">Although these are rare occurrences, the impact on quality of life (QOL) </span>
<span id="t11_147" class="t s4_147">and the need for continual supportive care are significant and open-ended. </span>
<span id="t12_147" class="t s4_147">Although local and regional disease may be surgically treatable, patients </span>
<span id="t13_147" class="t s4_147">with distant metastases may not benefit from surgery, and therefore their </span>
<span id="t14_147" class="t s4_147">disease is deemed inoperable. In incurable situations, surgery may still be </span>
<span id="t15_147" class="t s4_147">considered for symptom palliation in select cases. Thus, patient choice or </span>
<span id="t16_147" class="t s4_147">a physician’s expectations regarding cure and morbidity will influence or </span>
<span id="t17_147" class="t s4_147">determine treatment. Patients with locally advanced but resectable tumors, </span>
<span id="t18_147" class="t s4_147">who can also be adequately treated without surgery, represent a very </span>
<span id="t19_147" class="t s4_147">important group that is distinct from patients with unresectable disease. </span>
<span id="t1a_147" class="t s4_147">Definitive treatment with RT alone or RT combined with systemic therapy </span>
<span id="t1b_147" class="t s4_147">may represent equivalent or preferable approaches to surgery in these </span>
<span id="t1c_147" class="t s4_147">individuals. Although such patients may not undergo surgery, their tumors </span>
<span id="t1d_147" class="t s4_147">should not be labeled as unresectable. Their disease is usually far less </span>
<span id="t1e_147" class="t s4_147">extensive than those with disease that truly cannot be removed. </span>
<span id="t1f_147" class="t s6_147">Comorbidity and Quality of Life </span>
<span id="t1g_147" class="t s3_147">Comorbidity </span>
<span id="t1h_147" class="t s4_147">Comorbidity refers to the presence of concomitant disease(s) (in addition </span>
<span id="t1i_147" class="t s4_147">to H&amp;N cancers) that may affect diagnosis, treatment, and prognosis. </span>
<span id="t1j_147" class="t s4_147">Documentation of comorbidity is important to facilitate optimal treatment </span>
<span id="t1k_147" class="t s4_147">selection. Comorbidity is known to be a strong independent predictor for </span>
<span id="t1l_147" class="t s4_147">mortality in patients with H&amp;N cancers, </span>
<span id="t1m_147" class="t s7_147">72,73 </span>
<span id="t1n_147" class="t s4_147">and it also influences QOL and </span>
<span id="t1o_147" class="t s4_147">health care costs and utilization. </span>
<span id="t1p_147" class="t s7_147">74-76 </span>
<span id="t1q_147" class="t s4_147">The Adult Comorbidity Evaluation-27 </span>
<span id="t1r_147" class="t s4_147">(ACE-27) is a validated instrument for assessing comorbidity in numerous </span>
<span id="t1s_147" class="t s4_147">cancer types including H&amp;N cancers. </span>
<span id="t1t_147" class="t s7_147">77 </span>
<span id="t1u_147" class="t s4_147">An important consideration when </span>
<span id="t1v_147" class="t s4_147">interpreting published clinical trial data is the applicability of the results to </span>
<span id="t1w_147" class="t s4_147">patients with significant comorbidities, who may have been </span>
<span id="t1x_147" class="t s4_147">ineligible/excluded from such studies. </span>
<span id="t1y_147" class="t s3_147">Quality of Life </span>
<span id="t1z_147" class="t s4_147">Health-related QOL issues are important in patients with H&amp;N cancers. </span>
<span id="t20_147" class="t s4_147">These tumors affect the patient’s basic physiologic functions (ie, the ability </span>
<span id="t21_147" class="t s4_147">to chew, swallow, and breathe), the senses (ie, taste, smell, hearing), and </span>
<span id="t22_147" class="t s4_147">uniquely human characteristics (ie, appearance, voice). </span><span id="t23_147" class="t s5_147">Health status </span>
<span id="t24_147" class="t s4_147">describes an individual’s physical, emotional, and social capabilities and </span>
<span id="t25_147" class="t s4_147">limitations. </span><span id="t26_147" class="t s5_147">Function </span><span id="t27_147" class="t s4_147">and </span><span id="t28_147" class="t s5_147">performance </span><span id="t29_147" class="t s4_147">refer to how well an individual is </span>
<span id="t2a_147" class="t s4_147">able to perform important roles, tasks, or activities. </span><span id="t2b_147" class="t s5_147">QOL </span><span id="t2c_147" class="t s4_147">differs because </span>
<span id="t2d_147" class="t s4_147">the central focus is on the </span><span id="t2e_147" class="t s5_147">value </span><span id="t2f_147" class="t s4_147">(determined by the patient alone) that </span>
<span id="t2g_147" class="t s4_147">individuals place on their health status and function. </span>
<span id="t2h_147" class="t s8_147">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
